What Researchers Did
The researchers randomly assigned 101 people with Long COVID to one of four groups that each had 10 sessions of breathing oxygen or air inside a pressure chamber, then compared symptoms, walking and thinking tests before and after.
What They Found
In this randomised, double-blind, placebo-controlled trial of 101 Long COVID patients, no significant differences in symptoms, functional scores or cognitive performance were found between any of the four groups after 10 chamber sessions. The groups were 100% oxygen at 2.5 atmospheres absolute, 40% oxygen at 2.5 atmospheres absolute, 100% oxygen at 1 atmosphere absolute, and 21% oxygen at 1 atmosphere absolute (the placebo group). Responses were highly variable, and some patients in the placebo group reported a significant improvement in well-being, but this was not reflected in any objective outcome score. No subgroup of patients responded better to any of the treatments.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract reports only 10 sessions and a three-month telephone follow-up, and it describes improvements in the placebo group as highly variable, so the findings apply only to this dose, schedule and patient group.